-
Gilgeous-Alexander scores 40 as Thunder clinch playoff berth
-
Venezuela stun United States to win World Baseball Classic
-
Stocks extend gains and oil dips as US, Israel, Iran continue strikes
-
Iran missile fire kills two in central Israel: medics
-
Britain, Rwanda in £100m court clash over migrant deal
-
'We will wait for each one': Ukrainians greet POWs with tears and cheers
-
UN watchdog says projectile struck Iran nuclear power plant
-
Trump faces impasse over Iran war
-
US Fed expected to hold rates steady as Iran war's shockwaves ripple
-
Former Australian Test wicketkeeper Haddin to coach NSW
-
China coach says team on right track despite Asian Cup heartache
-
Oscars audience drops, viewing figures show
-
Resilient Australia 'need to be better' in Women's Asian Cup final
-
Gio Reyna picked for US squad as Pochettino says World Cup roster still 'open'
-
Colombia, Ecuador leaders clash over bomb dropped near border
-
PSG, Real Madrid and Arsenal march into Champions League last eight
-
'Incomplete' Man City not what they once were, says Guardiola
-
US judge orders Trump admin to bring VOA employees back to work
-
White House pressure on Cuba mounts as island fights power cut
-
Arteta hails 'magical' Eze after Arsenal star sinks Leverkusen
-
Senegal stripped of AFCON title, Morocco declared champions
-
Nvidia says restarting production of China-bound chips
-
Panic as Israel army urges residents to evacuate south Lebanon's Tyre area
-
Real Madrid 'change' under Champions League spotlight: Vinicius
-
Real Madrid dump Man City out of Champions League once more
-
Clinical PSG bury Chelsea to reach Champions League quarter-finals
-
Eze rocket fires Arsenal into Champions League quarters
-
US airlines still see strong demand as jet fuel worries loom
-
Milei blasts Iran on anniversary of attack on Israeli embassy
-
USS Gerald R. Ford: the world's biggest aircraft carrier
-
US, European stocks rise despite latest jump in oil prices
-
Sporting Lisbon thrash Bodo/Glimt to reach Champions League quarters
-
Irish PM pushes Trump on Iran -- politely
-
Arizona charges prediction market Kalshi with illegal election betting
-
Leftist New York mayor under pressure on Irish unity question
-
Atletico boss Simeone defends Spurs star Romero
-
Iran vets friendly ships for Hormuz passage: trackers
-
Iran women's football team arrive in Turkey on way home
-
Mexico prepared to host Iran World Cup games, says president
-
Trump blasts 'foolish' NATO on Iran, says US needs no help
-
Slot vows to win back support of frustrated Liverpool fans
-
In Ukraine, Sean Penn gifted Oscar made from train carriage hit by Russia
-
Ships in Gulf risk shortages on board, industry warns
-
White House piles pressure on Cuba as island fights power cut
-
Newcastle must grow under Camp Nou pressure: Howe
-
Trump says to make delayed China trip in 'five or six weeks'
-
Kompany warns of complacency as injury-hit Bayern host Atalanta
-
SAS cancels flights after fuel prices surge
-
New particle discovered by Large Hadron Collider
-
Lebanon says Israeli strikes kill soldiers, as shelters overflow
Brazil's banana spider aids erectile dysfunction treatment
Three decades ago, Brazilian researchers began studying a curious side effect from banana spider bites: the toxin left victims with priapism, a painful and persistent erection.
The scientists were inspired to develop a synthetic molecule using some properties of the spider's poison to create a gel to treat erectile dysfunction, which is now undergoing promising clinical trials.
Covered in thick brown hair, and with a maximum size of up to 15 centimeters (six inches), the arachnid is one of the most poisonous in the world.
It is found in several South American countries, and was nicknamed for its common presence in banana plantations, but it is also called the "wandering spider" or "armed spider."
In the southeastern Brazilian state of Minas Gerais, it is found in rural areas as well as urban centers.
At the Ezequiel Dias Foundation (FUNED), a medical research center in the state's capital Belo Horizonte, a biologist delicately grabs one of the spiders with a pair of tweezers and stimulates its fangs to get a few drops of venom.
FUNED then sends the venom to the Federal University of Minas Gerais (UFMG) which has been researching which component could be replicated to treat erectile dysfunction, which affects tens of millions of men around the world.
"The venom is only used to learn the properties of the molecule" which causes the priapism in bite victims, said Maria Elena de Lima, a UFMG researcher.
Brazilian biotech company Biozeus has bought the patent for the molecule.
The company wants to sell it in an ointment, which would be rubbed on the penis when required, resulting in an erection in a few minutes, said de Lima.
The molecule triggers the release of nitric oxide, which is essential for an erection as it increases blood circulation and allows blood vessels to widen.
De Lima said the research could be especially useful in the fight against cancer, as men suffering prostate cancer often refuse a procedure to remove the prostate because it can damage nerves and lead to erectile dysfunction.
After the first phase of clinical trials was approved by Brazil's Anvisa regulatory agency, the medication has now moved into the second of three phases prior to being approved for sale.
De Lima said the discovery of a potential erectile dysfunction treatment was a message "not to destroy animals, even poisonous ones, because there is a real library of molecules that are still unknown."
C.Garcia--AMWN